Hana Biosciences Announces Second Quarter 2008 Results
August 11, 2008 16:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 11, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced...
Threshold Pharmaceuticals Reports Second Quarter 2008 Financial Results
August 07, 2008 16:00 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., Aug. 7, 2008 (PRIME NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today reported financial results for the second quarter ended June 30, 2008.
The net loss for the...
DelSite Subsidiary Sabila Industrial in Costa Rica Completes ISO 9001:2000 Inspection
August 04, 2008 12:31 ET
|
DelSite, Inc.
* Sabila Industrial ISO-Certified for More Than Five Years
* No Significant Incidences of Nonconformance Found
* Continued Dedication to Quality
IRVING, Texas, Aug....
Global Biotechnology Company Licenses WinNonlin AutoPilot
July 31, 2008 12:18 ET
|
Pharsight Corporation
MOUNTAIN VIEW, Calif., July 31, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug...
Momenta Pharmaceuticals Announces Results From a Phase 1 Study of M118 Administered as a Subcutaneous Injection
July 29, 2008 13:45 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., July 29, 2008 (PRIME NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Athersys Added to Russell Microcap Index
July 02, 2008 08:30 ET
|
Athersys, Inc.
CLEVELAND, July 2, 2008 (PRIME NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it was added to the Russell Microcap(r) Index when Russell Investments reconstituted its comprehensive family...
DelSite Announces Development of Unique Synthetic Typhoid Vi Polysaccharide Vaccine Candidate
June 26, 2008 08:59 ET
|
DelSite, Inc.
* Safer and More Economical Approach Against a Major Infectious
Disease That Causes 500,000 to 600,000 Deaths Worldwide Per Year
* Chemical Composition Similar to Marketed Typhoid...
Biotage has Received its Largest Order to Date
August 11, 2005 07:07 ET
|
Biotage AB
STOCKHOLM, Sweden, Aug. 11, 2005 (PRIMEZONE) -- Biotage has received the company's largest single order to date. It includes 31 instruments and totals approx. 15 MSEK. The customer is one of the...
Fidelity Fund Acquires 5.13 Percent Interest in Crucell
June 28, 2005 02:07 ET
|
Crucell N.V.
LEIDEN, Netherlands, June 28, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that Fidelity's FID Growth Company Fund has acquired a 5.13%...
Astex Achieves Drug Discovery Milestone with Boehringer Ingelheim
February 14, 2005 02:35 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Feb. 14, 2005 (PRIMEZONE) -- * Astex, the fragment-based drug discovery and development company, today announced that it has successfully achieved the first milestone in its drug...